rt112 84 (AcceGen Biotechnology)
Structured Review
Rt112 84, supplied by AcceGen Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt112/RT-112+84/pm41252152-305-44-45
Average 93 stars, based on 1 article reviews
Images
Related Articles
Multiple Displacement Amplification:Article Title: EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. Article Snippet: .. The following cell lines were used and purchased from American Type Culture Collection (ATCC) or indicated vendors: FaDu (ATCC HTB- 43), COR- L105 (Millipore Sigma 92031918), HCC1954 (CRL- 2338), SiHa (ATCC HTB- 35), Jurkat NFAT reporter (Signosis SL- 0032- FP), Raji (ATCC CCL- 86), Article Title: EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors Article Snippet: CP149 negative control and pembrolizumab were purchased from BioXCell. .. The following cell lines were used and purchased from American Type Culture Collection (ATCC) or indicated vendors: FaDu (ATCC HTB-43), COR-L105 (Millipore Sigma 92031918), HCC1954 (CRL-2338), SiHa (ATCC HTB-35), Jurkat NFAT reporter (Signosis SL-0032-FP), Raji (ATCC CCL-86), |

